Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease
Helmine Hochstrasser(University of Tübingen), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Jens Pahnke(Latvia University of Life Sciences and Technologies), Uwe Walter(German Center for Neurodegenerative Diseases), Ilona Csóti(German Center for Neurodegenerative Diseases), Georg Becker, Björn Zeiler(Johannes Gutenberg University Mainz), Stefanie Behnke(University Medical Center), Peter Bauer(Bioinova (Czechia)), A. Bornemann, Jörg Spiegel(Hertie Institute for Clinical Brain Research)
Cited by 112
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846